深圳9527
05-21
这篇文章不错，转发给大家看看
恒瑞医药：每股H股发售价定为44.05港元
恒瑞医药香港IPO定价上限为44.05元
恒瑞医药在香港IPO中确定定价上限为44.05元，预计集资98.9亿元，超额认购409倍。公司展现出对市场前景的信心，可能进一步巩固其行业地位。
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":437418244883136,"tweetId":"437418244883136","gmtCreate":1747821998668,"gmtModify":1747823793699,"author":{"id":4175442378221512,"idStr":"4175442378221512","authorId":4175442378221512,"authorIdStr":"4175442378221512","name":"深圳9527","avatar":"https://static.tigerbbs.com/f554b9587872fe501894c74c38ef23a0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[{"themeId":"00417d1c9fabb8d35421e92b7c290bbb","categoryId":"2929bb7468f5415f853fd96fb35d7c3b","name":"恒瑞医药香港IPO定价上限为44.05元","type":2,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":00417d1c9fabb8d35421e92b7c290bbb}&rnconfig={\"headerBarHidden\": true}","description":"恒瑞医药在香港IPO中确定定价上限为44.05元，预计集资98.9亿元，超额认购409倍。公司展现出对市场前景的信心，可能进一步巩固其行业地位。"}],"images":[{"img":"https://static.tigerbbs.com/b27350d6109f1d562cca11cb03ebd401"}],"coverImages":[{"img":"https://static.tigerbbs.com/b27350d6109f1d562cca11cb03ebd401"}],"html":"<html><head></head><body>这篇文章不错，转发给大家看看<t-t type=\"img\" src=\"https://static.tigerbbs.com/b27350d6109f1d562cca11cb03ebd401\"></t-t></body></html>","htmlText":"<html><head></head><body>这篇文章不错，转发给大家看看<t-t type=\"img\" src=\"https://static.tigerbbs.com/b27350d6109f1d562cca11cb03ebd401\"></t-t></body></html>","text":"这篇文章不错，转发给大家看看","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/437418244883136","repostId":2537590988,"repostType":2,"repost":{"id":"2537590988","kind":"news","pubTimestamp":1747820442,"share":"https://www.laohu8.com/m/news/2537590988?lang=&edition=full","pubTime":"2025-05-21 17:40","market":"hk","language":"zh","title":"恒瑞医药：每股H股发售价定为44.05港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537590988","media":"智通财经","summary":"$恒瑞医药$发布公告，于2025年5月21日(星期三)，发售价已厘定为每股H股44.05港元。假设全球发售于2025年5月23日(星期五)上午8时正或之前成为无条件，则预计H股将于2025年5月23日(星期五)上午九时正开始在联交所主板买卖。H股将以每手200股H股买卖。H股的股份代号为1276。","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a>发布公告，于2025年5月21日(星期三)，发售价已厘定为每股H股44.05港元(不包括1%经纪佣金、0.0027%证监会交易征费、0.00565%联交所交易费及0.00015%会财局交易征费)。</p><p>公司预期于2025年5月22日(星期四)以招股章程“如何申请香港发售股份 B.公布结果”一节所述的方式公布国际发售的踊跃程度、香港公开发售的申请水平、香港发售股份的分配基准及香港公开发售的分配结果。</p><p>假设全球发售于2025年5月23日(星期五)上午8时正或之前成为无条件，则预计H股将于2025年5月23日(星期五)上午九时正开始在联交所主板买卖。H股将以每手200股H股买卖。H股的股份代号为1276。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药：每股H股发售价定为44.05港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药：每股H股发售价定为44.05港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-21 17:40 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/1295845.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>恒瑞医药发布公告，于2025年5月21日(星期三)，发售价已厘定为每股H股44.05港元(不包括1%经纪佣金、0.0027%证监会交易征费、0.00565%联交所交易费及0.00015%会财局交易征费)。公司预期于2025年5月22日(星期四)以招股章程“如何申请香港发售股份 B.公布结果”一节所述的方式公布国际发售的踊跃程度、香港公开发售的申请水平、香港发售股份的分配基准及香港公开发售的分配结果...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1295845.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/cce0dc68349afa0976475c67b75849b9","relate_stocks":{"600276":"恒瑞医药","BK0060":"抗癌","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","BK0196":"行业龙头","BK0239":"医药制造","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","01276":"恒瑞医药","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","BK0183":"MSCI概念","BK0188":"融资融券","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","BK0012":"证金概念","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK0028":"国家队"},"source_url":"http://www.zhitongcaijing.com/content/detail/1295845.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2537590988","content_text":"恒瑞医药发布公告，于2025年5月21日(星期三)，发售价已厘定为每股H股44.05港元(不包括1%经纪佣金、0.0027%证监会交易征费、0.00565%联交所交易费及0.00015%会财局交易征费)。公司预期于2025年5月22日(星期四)以招股章程“如何申请香港发售股份 B.公布结果”一节所述的方式公布国际发售的踊跃程度、香港公开发售的申请水平、香港发售股份的分配基准及香港公开发售的分配结果。假设全球发售于2025年5月23日(星期五)上午8时正或之前成为无条件，则预计H股将于2025年5月23日(星期五)上午九时正开始在联交所主板买卖。H股将以每手200股H股买卖。H股的股份代号为1276。","news_type":1,"symbols_score_info":{"600276":1,"01276":1,"MCHmain":1}},"isVote":1,"tweetType":1,"viewCount":483,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":27,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/437418244883136"}
精彩评论